We are live on
!
Find out more
HP
HealthInvest Partners Portfolio holdings
AUM
$372M
1-Year Est. Return
59.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$196M
AUM Growth
+$51.4M
(+36%)
Cap. Flow
+$41M
Cap. Flow
% of AUM
20.95%
Top 10 Holdings %
Top 10 Hldgs %
98.21%
Holding
15
New
–
Increased
9
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$12.8M |
| 2 |
Pfizer
PFE
|
+$10.9M |
| 3 |
Elevance Health
ELV
|
+$9.75M |
| 4 |
Charles River Laboratories
CRL
|
+$7.1M |
| 5 |
AET
Aetna Inc
AET
|
+$6.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MR
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
|
+$11.9M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$1.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.94% |
| 2 | Financials | 22.76% |
| 3 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$143B
| $28.4M | 14.49% |
891,684
+335,172
| +60% | +$10.9M |
|
|
2
Gilead Sciences
GILD
$165B
| $28.1M | 14.37% |
240,300
+117,000
| +95% | +$12.8M |
|
|
3
Elevance Health
ELV
$81.5B
| $28M | 14.31% |
170,700
+61,000
| +56% | +$9.75M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $27.5M | 14.06% |
215,900
+57,000
| +36% | +$6.51M |
|
|
LPNT
5
DELISTED
LifePoint Health, Inc.
LPNT
| $18.1M | 9.26% |
208,430
+37,000
| +22% | +$2.8M |
|
|
GTS
6
DELISTED
Triple-S Management Corporation
GTS
| $17M | 8.7% |
697,405
+194,366
| +39% | +$4.13M |
|
|
7
Charles River Laboratories
CRL
$11.3B
| $16.9M | 8.64% |
240,320
+96,000
| +67% | +$7.1M |
|
|
MGLN
8
DELISTED
Magellan Health Services, Inc.
MGLN
| $16.8M | 8.57% |
239,442
-21,164
| -8% | -$1.44M |
|
|
AIQ
9
DELISTED
Alliance Healthcare Services
AIQ
| $9.8M | 5.01% |
524,538
| – | – |
|
|
SURG
10
DELISTED
SYNERGETICS USA, INC.
SURG
| $1.56M | 0.8% |
332,687
+70,395
| +27% | +$341K |
|
11
Artivion
AORT
$1.34B
| $1.01M | 0.52% |
90,000
| – | – |
|
|
SSRG
12
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $990K | 0.51% |
113,479
| – | – |
|
13
ImmuCell
ICCC
$99.6M
| $854K | 0.44% |
108,750
+2,200
| +2% | +$15.1K |
|
|
NOTV
14
DELISTED
Inotiv
NOTV
| $644K | 0.33% |
320,234
| – | – |
|
|
MR
15
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| – | – |
-435,012
| Closed | -$11.9M |
|
Similar funds
KP
AWA
TCM
SAAM
SC
PAA
PC
BOCH
HealthInvest Partners's Q2 2015 Portfolio in Review
As of Q2 2015, HealthInvest Partners held 15 positions worth $196M, up 36% from $144M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
HealthInvest Partners deployed $41M of net new capital in Q2 2015, adding to 9 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 72% a quarter earlier, followed by Financials and Utilities.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $1.44M trimmed.
- HealthInvest Partners added most to Gilead Sciences in Q2 2015, an estimated $12.8M increase.
- HealthInvest Partners's biggest Q2 2015 reduction was Magellan Health Services, Inc., cutting an estimated $1.44M.
- HealthInvest Partners fully exited MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2015, selling an estimated $11.9M.
- HealthInvest Partners's ten largest holdings make up 98% of its $196M portfolio in Q2 2015.
- HealthInvest Partners opened 0 new positions and closed 1 in Q2 2015.
- HealthInvest Partners's portfolio value rose 36% quarter-over-quarter to $196M.
Based on HealthInvest Partners's 13F filing for Q2 2015, filed 20 Jul 2015.